EMA consults on ICH S12 guideline, shares comments on PFDD reflection paper
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsEuropePharmaceuticalsPreclinical studyRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsEuropePharmaceuticalsPreclinical study